Search Within

Alexander Edward Drilon

Formats
  1. Meeting Abstract (373)
  2. Journal Article (219)
  3. Review (23)
  4. Editorial (6)
  5. Correspondence (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Book Whole (1)
  9. Guidelines (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (631)
  2. Solid Tumor Oncology Division (631)
  3. Thoracic Oncology (631)
  4. Department of Pathology and Laboratory Medicine (205)
  5. GSK Faculty (187)
  6. Human Oncology and Pathogenesis Program (156)

More Groups

People
  1. Marc Ladanyi (121)
  2. Mark Kris (89)
  3. Maria Arcila (82)
  4. David Hyman (78)
  5. Bob Li (65)
  6. Charles Rudin (64)

More People

Years
  1. 2025 (16)
  2. 2024 (61)
  3. 2023 (67)
  4. 2022 (85)
  5. 2021 (76)
  6. 2020 (81)

More Years

Publications
  1. Journal of Clinical Oncology (138)
  2. Annals of Oncology (94)
  3. Journal of Thoracic Oncology (84)
  4. Clinical Cancer Research (31)
  5. JCO Precision Oncology (24)
  6. Cancer Research (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (164)
  2. Elsevier Inc. (118)
  3. Oxford University Press (113)
  4. American Association for Cancer Research (77)
  5. Nature Publishing Group (27)
  6. S. Karger AG (23)

More Publishers

Results (631)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preclinical and ongoing phase I study data of the CHK1 inhibitor BBI-355 in development for patients with oncogene amplification on extrachromosomal DNA (ecDNA)
    Meeting Abstract

    Drilon, A.; Rivera, I. I. R.; Spira, A. I.; Sharma, M. R.; Hansen, R.; Chowdhry, S.; Kasibhatla, S.; Tewari, A.; Weymer, S.; Wagner, K.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib (laro) as first-line treatment for patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer
    Meeting Abstract

    Hong, D. S.; Xu, R. H.; McDermott, R. S.; Shen, L.; Dierselhuis, M. P.; Doz, F.; Tahara, M.; Bernard-Gauthier, V.; Norenberg, R.; Brega, N.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK plus ) advanced solid tumors, including NSCLC: Update from the phase I/II TRIDENT-1 trial
    Meeting Abstract

    Solomon, B. J.; Drilon, A.; Lin, J. J.; Bazhenova, L.; Goto, K.; De Langen, J.; Kim, D. W.; Wolf, J.; Springfeld, C.; Popat, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Schram, A.; Goto, K.; Kim, D. W.; Hollebecque, A.; Rha, S. Y.; Nishino, K.; Duruisseaux, M.; Umemoto, K.; Park, J. O.; Leighl, N.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib in patients with MET-altered lung cancers
    Meeting Abstract

    Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers
    Meeting Abstract

    Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Spontaneous bilateral chylothorax development during alectinib therapy for ALK-rearranged NSCLC—A case report
    Journal Article

    Bajaj, S.; Chow, A.; Drilon, A.; Kalchiem-Dekel, O.
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Precision oncology: 2023 in review
    Review

    Murciano-Goroff, Y. R.; Suehnholz, S. P.; Drilon, A.; Chakravarty, D.
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion-positive NSCLC
    Journal Article

    Caicun, Z.; Solomon, B.; Loong, H. H.; Park, K.; Pérol, M.; Arriola, E.; Novello, S.; Han, B.; Zhou, J.; Ardizzoni, A.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
    Journal Article

    Kummar, S.; Shen, L.; Hong, D. S.; McDermott, R.; Keedy, V. L.; Casanova, M.; Demetri, G. D.; Dowlati, A.; Melcón, S. G.; Lassen, U. N.; more...
    Cancer (2023)

    Fulltext@MSK | Save